Tandem Diabetes Care, Inc. (TNDM) has a consensus analyst rating of Buy, based on 39 analysts covering the stock. Of those, 24 recommend buying, 15 recommend holding, and 0 recommend selling.
The analyst consensus price target for TNDM is $30.50, representing a +44.5% upside from the current price of $21.11. Price targets range from a low of $21.00 to a high of $56.00.
